Medical Devices US

US Prenatal Genetic Testing Market Analysis, 2024–2034

US Prenatal Genetic Testing Market Industry Trends and Forecast to 2034: Segmented by (Test, Condition, End User, Region) - Growth, Market Size, Future Prospects & Competitive Analysis, 2024-2034

Overview

Market Dashboard

US · 2024–2034 · estimates

Values shown here are estimates. Researched 2024 historical, 2025 base-year and 2026–2034 forecast values are prepared with the full report.

Estimate 2024 $2.60 Bn Estimated value
Estimate 2025 $2.81 Bn 42.3% of the global market
Projected 2034 $5.72 Bn 103.3% Adds $2.91 Bn over 9 forecast years
CAGR 2025–2034 8.2% Faster than 63% of 173 Medical Devices markets here
Key players 5
  • US is 42.28% of the global market.
  • In North America, the largest is US (this report) at $2.81 Bn.
  • Fastest growing: Canada at 10.3% a year.
  • US ranks 1st of 2 by size in North America.

Market size projection

US

Source: Acuitas Health Analytics. Full methods, sources and usage terms come with report purchase.

Value added each year

$2.91 Bn total, 2026–2034

Year-by-year market size, 2024–2034
Prenatal Genetic Testing Market market size by year, US
YearMarket sizeChange that yearSince 2025
2024 (estimate) $2.60 Bn — —
2025 (base) $2.81 Bn +$213.3 Mn —
2026 (forecast) $3.04 Bn +$230.7 Mn +8.2%
2027 (forecast) $3.29 Bn +$249.7 Mn +17.1%
2028 (forecast) $3.56 Bn +$270.1 Mn +26.7%
2029 (forecast) $3.86 Bn +$292.3 Mn +37.1%
2030 (forecast) $4.17 Bn +$316.3 Mn +48.3%
2031 (forecast) $4.52 Bn +$342.2 Mn +60.5%
2032 (forecast) $4.89 Bn +$370.2 Mn +73.6%
2033 (forecast) $5.29 Bn +$400.6 Mn +87.9%
2034 (forecast) $5.72 Bn +$433.5 Mn +103.3%

Estimates. Each year is projected from our earlier market estimate and its CAGR. Researched values come with the full report.

Same market worldwide

By geography

  1. Global $6.66 Bn
  2. North America $3.24 Bn
  3. US (this report) $2.81 Bn
  4. APAC $1.50 Bn
  5. Europe $1.22 Bn
  6. China $609.1 Mn
  7. Canada $596.3 Mn
  8. Japan $359.1 Mn
  9. Latin America $295.0 Mn
  10. Germany $271.6 Mn
  11. Middle East $237.5 Mn
  12. Brazil $187.2 Mn
  13. France $162.9 Mn
  14. Italy $154.2 Mn
  15. UK $145.1 Mn
  16. Ecuador $126.2 Mn
  17. Saudi Arabia $124.0 Mn
  18. India $122.7 Mn
  19. Africa $117.8 Mn
  20. Spain $108.4 Mn
  21. Mexico $96.9 Mn
  22. Australia $74.5 Mn
  23. New Zealand $68.2 Mn
  24. Russia $64.5 Mn
  25. South Africa $38.2 Mn
  26. UAE $30.4 Mn
  27. Egypt $21.2 Mn
  28. Philippines $16.7 Mn
  29. Hong Kong $12.4 Mn
  30. Malaysia $10.0 Mn
  31. Thailand $8.5 Mn
  32. Singapore $7.0 Mn
  33. Kenya $4.7 Mn

The US Prenatal Genetic Testing Market Analysis Executive Summary

Prenatal genetic tests, such as non-invasive prenatal tests, check a baby's DNA for genetic conditions during pregnancy, often from the mother's blood.

Key segments of the prenatal Genetic Testing market include test (NIPT, Carrier Screening and Amniocentesis Testing) and condition (Down Syndrome, Sex Chromosome Disorders and Microdeletions).

US Prenatal Genetic Testing Market Dynamics

Market Growth Drivers

Demand for earlier and faster diagnosis, growth of testing outside hospitals, new molecular technologies and the shift to preventive care are driving the prenatal Genetic Testing market.

Opportunity

Home testing, connected devices that send results to doctors and multiplex tests that check many conditions at once give the prenatal Genetic Testing market room to grow, especially in emerging markets.

Market Restraints

Pricing pressure, uneven reimbursement for new tests, regulatory approval times and the need for skilled lab staff hold back the prenatal Genetic Testing market.

Competitive Landscape for Prenatal Genetic Testing Market in US

The prenatal Genetic Testing market is moderately concentrated. Leading companies compete on product innovation, clinical evidence, pricing and geographic reach, and use partnerships and acquisitions to expand their portfolios.

Key Players

Healthcare Policies and Regulatory Landscape for Prenatal Genetic Testing Market in US

Policy changes and Reimbursement scenario

Medical device rules, such as the US FDA 510(k) and PMA pathways and the EU Medical Device Regulation, govern how prenatal Genetic Testing products are approved and monitored. Reimbursement codes and hospital purchasing policies decide how widely they are used in US.

Beyond the market numbers

Research, trials and patients

What doctors and scientists are doing in Prenatal Genetic Testing right now, from free public sources.

Latest research 242 papers since 2021 (worldwide)

  1. Measuring the Utility of Prenatal Exome Sequencing Using the Clinician-Reported Genetic Testing Utility InDEx for Prenatal Care: A Retrospective Multicentre Study. Prenatal diagnosis, 2026
  2. Case Report: Prenatal and postnatal clinical manifestations of 15q duplication syndrome: a single longitudinal case combined with pooled analysis of 35 prenatal cases. Frontiers in medicine, 2026
  3. Case Report: Short rib-thoracic dysplasia type 3 presenting with predominant respiratory manifestations. Frontiers in pediatrics, 2026
  4. Prenatal Sonographic Features of Heterozygous DLL1 Single-Nucleotide Variants and 6q27 Deletions: A Single Referral Center Retrospective Case Series. Prenatal diagnosis, 2026
  5. Opportunistic Prenatal Genetic Testing During Fetoscopic Laser Surgery for Twin-Twin Transfusion Syndrome. Prenatal diagnosis, 2026
Search all of them on PubMed (opens in a new tab)

Sources: PubMed (US National Library of Medicine), ClinicalTrials.gov, World Bank. Fetched 12 Nov 2026. Papers and trials are found by search words, so the counts are a guide. Titles only; read each paper at its source.

Public data, with sources

Prenatal Genetic Testing in context

The US compared

  • Health spending per person: 13,473 US$ per person (2023). World: 1,317 US$ per person (2023).[1]
  • Doctors: 3.68 per 1,000 people (2022). World: 1.86 per 1,000 people (2022).[2]
  • People aged 65 and over: 18.4% of people (2025). World: 10.4% of people (2025).[3]

Questions, answered with public data

How much research is published on Prenatal Genetic Testing?
PubMed lists 242 papers added since January 2021 that match this market, worldwide.[4]

[1] World Bank Open Data, Health spending per person (US$ per person). Retrieved 13 Nov 2026.

[2] World Bank Open Data, Doctors (per 1,000 people). Retrieved 13 Nov 2026.

[3] World Bank Open Data, People aged 65 and over (% of people). Retrieved 13 Nov 2026.

[4] PubMed, Papers added since 1 January 2021 matching this market. Retrieved 12 Nov 2026.

Free data on this topic

Get a free sample The table of contents and sample pages. No payment needed. Request sample Consult Us Questions about Prenatal Genetic Testing in US? Our analysts can size it for your plan. Talk to us See the public data Health figures for every country, free. Open the Public Health Dashboard

From our blog

Women's Health Supplements: A Growing FocusAnaemia affects about half a billion women worldwide, and folic acid before pregnancy prevents serious birth… Iron Supplements and the Fight Against AnaemiaIron supplements are the first line against anaemia. Why taking them is the hard part, and how the market is… Dermatology Diagnostics: AI and Skin HealthSkin cancers caused over 1.5 million new cases in 2022. Imaging and AI tools are changing how skin conditions…
Back to Catalogue
Keep exploring

Related Medical Devices reports in US

See all
Same topic, other categories

Related on diagnostics and lab testing and maternal

See the topic